Literatures

Primary Site >> Pancreatic Cancer

Gene >> ERBB2

1.
Journal:	J Pathol. 1990 Jul;161(3):195-200.
Title:	The c-erb B-2 proto-oncogene in human pancreatic cancer.
Author:	Hall, P A\|Hughes, C M\|Staddon, S L\|Richman, P I\|Gullick, W J\|Lemoine, N R
PMID:	2202801

2.
Journal:	Pathobiology. 1991;59(1):46-52.
Title:	Expression of c-erbB-2 in human pancreatic adenocarcinomas.
Author:	Williams, T M\|Weiner, D B\|Greene, M I\|Maguire, H C Jr
PMID:	1675057

3.
Journal:	Nihon Ika Daigaku Zasshi. 1992 Feb;59(1):51-61.
Title:	The immunohistochemical expressions of epidermal growth factors, epidermal growth factor receptors and c-erbB-2 oncoprotein in human pancreatic cancer.
Author:	Yamanaka, Y
PMID:	1347773

4.
Journal:	Zhonghua Zhong Liu Za Zhi. 1993 Jul;15(4):275-8.
Title:	[Gene expression of TGF alpha, TGF beta 1 and C-erbB2 oncogene in human pancreatic carcinoma cell lines].
Author:	Chen, J
PMID:	7909745

5.
Journal:	Jpn J Cancer Res. 1993 Feb;84(2):147-52.
Title:	Construction of immunoradiometric assay for circulating c-erbB-2 protooncogene product in advanced breast cancer patients.
Author:	Hosono, M\|Saga, T\|Sakahara, H\|Kobayashi, H\|Shirato, M\|Endo, K\|Yamamoto, T\|Akiyama, T\|Toyoshima, K\|Konishi, J
PMID:	8096502

6.
Journal:	Hum Pathol. 1993 Oct;24(10):1127-34.
Title:	Overexpression of HER2/neu oncogene in human pancreatic carcinoma.
Author:	Yamanaka, Y\|Friess, H\|Kobrin, M S\|Buchler, M\|Kunz, J\|Beger, H G\|Korc, M
PMID:	8104858

7.
Journal:	Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8972-6.
Title:	Inverse regulation of human ERBB2 and epidermal growth factor receptors by tumor necrosis factor alpha.
Author:	Kalthoff, H\|Roeder, C\|Gieseking, J\|Humburg, I\|Schmiegel, W
PMID:	8105469

8.
Journal:	Gene Ther. 1994 May;1(3):170-5.
Title:	Gene therapy for cancer using tumour-specific prodrug activation.
Author:	Harris, J D\|Gutierrez, A A\|Hurst, H C\|Sikora, K\|Lemoine, N R
PMID:	7584078

9.
Journal:	Virchows Arch. 1994;425(4):357-67.
Title:	Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
Author:	Sessa, F\|Solcia, E\|Capella, C\|Bonato, M\|Scarpa, A\|Zamboni, G\|Pellegata, N S\|Ranzani, G N\|Rickaert, F\|Kloppel, G
PMID:	7820300

10.
Journal:	Hum Pathol. 1994 May;25(5):549-50.
Title:	HER2/neu immunostaining in pancreatic carcinoma.
Author:	Battifora, H
PMID:	7911120

11.
Journal:	Zentralbl Pathol. 1994 Aug;140(3):265-70.
Title:	Expression of EGF, TGF-alpha, EGFR and c-erbB2 genes and their gene products in human pancreatic carcinoma cell lines.
Author:	Chen, J\|Liu, T H
PMID:	7947634

12.
Journal:	Int J Pancreatol. 1995 Aug;18(1):15-23.
Title:	Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.
Author:	Oikawa, T\|Hitomi, J\|Kono, A\|Kaneko, E\|Yamaguchi, K
PMID:	7594766

13.
Journal:	Oncology. 1995 Sep-Oct;52(5):392-6.
Title:	Elevated serum c-erbB-2 protein levels in patients with pancreatic cancer: correlation to metastasis and shorter survival.
Author:	Okada, N\|Ohshio, G\|Yamaki, K\|Imamura, T\|Imamura, M
PMID:	7637957

14.
Journal:	Anticancer Res. 1995 Jul-Aug;15(4):1135-9.
Title:	In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin.
Author:	Schultz, R M\|Merriman, R L\|Andis, S L\|Bonjouklian, R\|Grindey, G B\|Rutherford, P G\|Gallegos, A\|Massey, K\|Powis, G
PMID:	7653991

15.
Journal:	Eur J Surg Oncol. 1995 Jun;21(3):251-3.
Title:	Oncogenes in cancer of the pancreas.
Author:	Sakorafas, G H\|Lazaris, A\|Tsiotou, A G\|Koullias, G\|Glinatsis, M T\|Golematis, B C
PMID:	7781791

16.
Journal:	Hum Pathol. 1996 Feb;27(2):119-24.
Title:	Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms.
Author:	Day, J D\|Digiuseppe, J A\|Yeo, C\|Lai-Goldman, M\|Anderson, S M\|Goodman, S N\|Kern, S E\|Hruban, R H
PMID:	8617452

17.
Journal:	J Pathol. 1996 Feb;178(2):140-5.
Title:	Overexpression of different members of the type 1 growth factor receptor family and their association with cell proliferation in periampullary carcinoma.
Author:	Vaidya, P\|Kawarada, Y\|Higashiguchi, T\|Yoshida, T\|Sakakura, T\|Yatani, R
PMID:	8683379

18.
Journal:	J Mol Med (Berl). 1996 Jan;74(1):35-42.
Title:	Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors.
Author:	Friess, H\|Berberat, P\|Schilling, M\|Kunz, J\|Korc, M\|Buchler, M W
PMID:	8834768

19.
Journal:	Pancreas. 1997 Apr;14(3):229-36.
Title:	HER-2/neu expression in pancreatic adenocarcinoma: relation to tumor differentiation and survival.
Author:	Dugan, M C\|Dergham, S T\|Kucway, R\|Singh, K\|Biernat, L\|Du, W\|Vaitkevicius, V K\|Crissman, J D\|Sarkar, F H
PMID:	9094152

20.
Journal:	Mod Pathol. 1997 Apr;10(4):372-9.
Title:	Hepatobiliary and pancreatic mucinous cystadenocarcinomas with mesenchymal stroma: analysis of estrogen receptors/progesterone receptors and expression of tumor-associated antigens.
Author:	Weihing, R R\|Shintaku, I P\|Geller, S A\|Petrovic, L M
PMID:	9110301

21.
Journal:	Eur J Immunol. 1997 May;27(5):1115-23.
Title:	The HER2/neu-derived peptide p654-662 is a tumor-associated antigen in human pancreatic cancer recognized by cytotoxic T lymphocytes.
Author:	Peiper, M\|Goedegebuure, P S\|Linehan, D C\|Ganguly, E\|Douville, C C\|Eberlein, T J
PMID:	9174600

22.
Journal:	Surgery. 1997 Aug;122(2):235-41; discussion 241-2.
Title:	Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells.
Author:	Peiper, M\|Goedegebuure, P S\|Eberlein, T J
PMID:	9288128

23.
Journal:	Int J Pancreatol. 1997 Jun;21(3):225-34.
Title:	Relationship of family cancer history to the expression of p53, p21WAF-1, HER-2/neu, and K-ras mutation in pancreatic adenocarcinoma.
Author:	Dergham, S T\|Dugan, M C\|Arlauskas, P\|Du, W\|Vaitkevicius, V K\|Crissman, J D\|Sarkar, F H
PMID:	9322121

24.
Journal:	Surg Oncol. 1997;6(1):1-18.
Title:	The molecular genetics of pancreatic cancer.
Author:	Howe, J R\|Conlon, K C
PMID:	9364657

25.
Journal:	Ciba Found Symp. 1997;209:124-37; discussion 137-41.
Title:	Differential oligonucleotide activity in cell culture versus mouse models.
Author:	Wickstrom, E\|Tyson, F L
PMID:	9383573

26.
Journal:	Cancer Res. 1998 Feb 15;58(4):732-6.
Title:	Her-2/neu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes.
Author:	Brossart, P\|Stuhler, G\|Flad, T\|Stevanovic, S\|Rammensee, H G\|Kanz, L\|Brugger, W
PMID:	9485028

27.
Journal:	Clin Cancer Res. 1998 Apr;4(4):887-94.
Title:	An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies.
Author:	Mohammad, R M\|Al-Katib, A\|Pettit, G R\|Vaitkevicius, V K\|Joshi, U\|Adsay, V\|Majumdar, A P\|Sarkar, F H
PMID:	9563882

28.
Journal:	Am J Pathol. 1998 Jul;153(1):263-9.
Title:	Comparative phenotypic studies of duct epithelial cell lines derived from normal human pancreas and pancreatic carcinoma.
Author:	Liu, N\|Furukawa, T\|Kobari, M\|Tsao, M S
PMID:	9665487

29.
Journal:	Front Biosci. 1998 Nov 1;3:E226-9.
Title:	Novel approaches in development for the treatment of pancreatic cancer.
Author:	Butera, J\|Malachovsky, M\|Rathore, R\|Safran, H
PMID:	9792896

30.
Journal:	Pol J Pathol. 1998;49(2):83-92.
Title:	HER-2/Neu expression as a progression marker in pancreatic intraepithelial neoplasia.
Author:	Tomaszewska, R\|Okon, K\|Nowak, K\|Stachura, J
PMID:	9798411

31.
Journal:	Crit Rev Eukaryot Gene Expr. 1998;8(3-4):377-93.
Title:	The molecular and cellular biology of pancreatic cancer.
Author:	Perugini, R A\|McDade, T P\|Vittimberga, F J Jr\|Callery, M P
PMID:	9807701

32.
Journal:	Pancreas. 1998 Nov;17(4):325-33.
Title:	Current concepts in pancreatic cancer: symposium summary.
Author:	Dugan, M C\|Sarkar, F H
PMID:	9821173

33.
Journal:	J Clin Pathol. 1998 Nov;51(11):865-7.
Title:	Pancreatic cancer and fibrinogen storage disease.
Author:	Radhi, J M\|Lukie, B E
PMID:	10193333

34.
Journal:	Hum Pathol. 1999 Feb;30(2):123-9.
Title:	Immunohistochemical evaluation of K-ras, p53, and HER-2/neu expression in hyperplastic, dysplastic, and carcinomatous lesions of the pancreas: evidence for multistep carcinogenesis.
Author:	Apple, S K\|Hecht, J R\|Lewin, D N\|Jahromi, S A\|Grody, W W\|Nieberg, R K
PMID:	10029438

35.
Journal:	Ann Oncol. 1999;10 Suppl 4:145-9.
Title:	Role of tumour markers, cytogenetics.
Author:	Lamerz, R
PMID:	10436809

36.
Journal:	Anticancer Res. 1999 Jul-Aug;19(4A):2471-5.
Title:	Pancreatic cancer associated ascites-derived CTL recognize a nine-amino-acid peptide GP2 derived from HER2/neu.
Author:	Peiper, M\|Goedegebuure, P S\|Izbicki, J R\|Eberlein, T J
PMID:	10470176

37.
Journal:	Ann Surg. 1999 Dec;230(6):767-74; discussion 774-5.
Title:	Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas.
Author:	Friess, H\|Wang, L\|Zhu, Z\|Gerber, R\|Schroder, M\|Fukuda, A\|Zimmermann, A\|Korc, M\|Buchler, M W
PMID:	10615931

38.
Journal:	Folia Med Cracov. 1999;40(1-2):101-41.
Title:	[Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
Author:	Tomaszewska, R
PMID:	10909469

39.
Journal:	Invest New Drugs. 2000 Feb;18(1):43-56.
Title:	Current approaches and future strategies for pancreatic carcinoma.
Author:	Wolff, R A\|Chiao, P\|Lenzi, R\|Pisters, P W\|Lee, J E\|Janjan, N A\|Crane, C H\|Evans, D B\|Abbruzzese, J L
PMID:	10830140

40.
Journal:	Hematology Am Soc Hematol Educ Program. 2000:394-408.
Title:	Emerging Therapies: Spectrum of Applications of Monoclonal Antibody Therapy.
Author:	Waldmann, Thomas A.\|Levy, Ronald\|Coller, Barry S.
PMID:	11701553

41.
Journal:	J Gastrointest Surg. 2001 Mar-Apr;5(2):139-46.
Title:	Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin).
Author:	Buchler, P\|Reber, H A\|Buchler, M C\|Roth, M A\|Buchler, M W\|Friess, H\|Isacoff, W H\|Hines, O J
PMID:	11331475

42.
Journal:	Arch Pathol Lab Med. 2001 Jun;125(6):765-9.
Title:	An immunostaining panel for diagnosis of malignancy in mucinous tumors of the pancreas.
Author:	Zhao, J\|Liang, S X\|Savas, L\|Banner, B F
PMID:	11371228

43.
Journal:	Cancer Res. 2001 Jun 15;61(12):4885-91.
Title:	Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors.
Author:	Kusama, T\|Mukai, M\|Iwasaki, T\|Tatsuta, M\|Matsumoto, Y\|Akedo, H\|Nakamura, H
PMID:	11406567

44.
Journal:	Hepatogastroenterology. 2001 May-Jun;48(39):879-83.
Title:	Immunohistochemical study of genetic alterations in intraductal and invasive ductal tumors of the pancreas.
Author:	Islam, H K\|Fujioka, Y\|Tomidokoro, T\|Sugiura, H\|Takahashi, T\|Kondo, S\|Katoh, H
PMID:	11462947

45.
Journal:	Cancer J. 2001 Jul-Aug;7(4):349-58.
Title:	Novel therapies for pancreatic cancer.
Author:	Wolff, R A
PMID:	11561610

46.
Journal:	Neoplasma. 2001;48(3):188-91.
Title:	Prognostic significance of c-erbB-2 gene expression in pancreatic cancer patients.
Author:	Novotny, J\|Petruzelka, L\|Vedralova, J\|Kleibl, Z\|Matous, B\|Juda, L
PMID:	11583287

47.
Journal:	Am J Clin Oncol. 2001 Oct;24(5):496-9.
Title:	Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.
Author:	Safran, H\|Steinhoff, M\|Mangray, S\|Rathore, R\|King, T C\|Chai, L\|Berzein, K\|Moore, T\|Iannitti, D\|Reiss, P\|Pasquariello, T\|Akerman, P\|Quirk, D\|Mass, R\|Goldstein, L\|Tantravahi, U
PMID:	11586103

48.
Journal:	Tidsskr Nor Laegeforen. 2001 Oct 20;121(25):2941-5.
Title:	[Tumor antigens presented to T helper lymphocytes--critical components of the cancer vaccine].
Author:	Bartnes, K
PMID:	11715777

49.
Journal:	Cancer Res. 2001 Dec 15;61(24):8830-7.
Title:	Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia.
Author:	Biankin, A V\|Kench, J G\|Morey, A L\|Lee, C S\|Biankin, S A\|Head, D R\|Hugh, T B\|Henshall, S M\|Sutherland, R L
PMID:	11751405

50.
Journal:	Cancer Immunol Immunother. 2002 Jan;50(11):615-24. Epub 2001 Nov 23.
Title:	HER-2/neu-derived peptide 884-899 is expressed by human breast, colorectal and pancreatic adenocarcinomas and is recognized by in-vitro-induced specific CD4(+) T cell clones.
Author:	Perez, Sonia A\|Sotiropoulou, Panagiota A\|Sotiriadou, Nectaria N\|Mamalaki, Avgi\|Gritzapis, Angelos D\|Echner, Hartmut\|Voelter, Wolfgang\|Pawelec, Graham\|Papamichail, Michael\|Baxevanis, Constantin N
PMID:	11807625

51.
Journal:	Gastroenterology. 2002 Jun;122(7):1898-912.
Title:	Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells.
Author:	Wagner, Martin\|Weber, Christoph K\|Bressau, Frank\|Greten, Florian R\|Stagge, Volker\|Ebert, Matthias\|Leach, Steven D\|Adler, Guido\|Schmid, Roland M
PMID:	12055597

52.
Journal:	Pancreas. 2002 Jul;25(1):e10-4.
Title:	Palliative MEFLEP therapy in advanced pancreatic cancer: excellent response in a patient with Her-2/neu amplification.
Author:	Chao, Yee\|Liu, Jacqueline Ming\|Li, Anna Fen Yau\|Perng, Ching Lin\|Tiu, Chue Mei\|King, Kuan Liang\|Chen, Li Tzong\|Lin, Wei Chun\|Lan, Chieh\|Whang-Peng, Jacqueline
PMID:	12131783

53.
Journal:	Anticancer Res. 2002 May-Jun;22(3):1593-7.
Title:	Role of immunohistochemical identification of Her-2/neu and detection of variability in overexpression in pancreatic carcinoma.
Author:	Koka, Vijay\|Potti, Anil\|Koch, Michael\|Fraiman, Genise\|Mehdi, Syed\|Levitt, Ralph
PMID:	12168842

54.
Journal:	Pancreas. 2002 Oct;25(3):e36-41.
Title:	Fas and Fas ligand expression in pancreatic adenocarcinoma.
Author:	Pernick, Nat L\|Sarkar, Fazlul H\|Tabaczka, Pam\|Kotcher, Glenn\|Frank, John\|Adsay, N Volkan
PMID:	12370548

55.
Journal:	Genes Chromosomes Cancer. 2002 Dec;35(4):353-8.
Title:	Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer.
Author:	Mahlamaki, Eija H\|Barlund, Maarit\|Tanner, Minna\|Gorunova, Ludmila\|Hoglund, Mattias\|Karhu, Ritva\|Kallioniemi, Anne
PMID:	12378529

56.
Journal:	Anticancer Res. 2002 Nov-Dec;22(6A):3357-63.
Title:	Comparison of various sources of antigen-presenting cells for the generation of GP2-tumor peptide specific cytotoxic T-lymphocytes.
Author:	Peiper, Matthias\|Goedegebuure, Peter S\|Alldinger, Ingo\|Knoefel, Wolfram Trudo\|Izbicki, Jakob R\|Eberlein, Timothy J
PMID:	12530087

57.
Journal:	Semin Oncol. 2002 Dec;29(6 Suppl 20):31-9.
Title:	Future directions in the treatment of pancreatic cancer.
Author:	Haller, Daniel G
PMID:	12577231

58.
Journal:	Int J Gastrointest Cancer. 2002;31(1-3):191-7.
Title:	Minute invasive ductal carcinoma of the residual pancreas after distal pancreatectomy for intraductal papillary-mucinous tumor.
Author:	Moriya, Toshiyuki\|Kimura, Wataru\|Sakurai, Fumiaki\|Semba, Shuho\|Ozawa, Koichiro\|Hirai, Ichiro\|Fuse, Akira
PMID:	12622431

59.
Journal:	Int J Gastrointest Cancer. 2002;32(2-3):91-106.
Title:	Drug development in pancreatic cancer: finally, biology begets therapy.
Author:	Cohen, Steven J\|Meropol, Neal J
PMID:	12794245

60.
Journal:	Semin Oncol. 2003 Jun;30(3 Suppl 7):15-24.
Title:	Preclinical studies with Erlotinib (Tarceva).
Author:	Akita, Robert W\|Sliwkowski, Mark X
PMID:	12840797

61.
Journal:	Anticancer Res. 2003 May-Jun;23(3B):2671-4.
Title:	HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma.
Author:	Potti, Anil\|Ganti, Apar Kishor\|Tendulkar, Ketki\|Chitajallu, Sidharth\|Sholes, Kaley\|Koch, Michael\|Kargas, Steven
PMID:	12894556

62.
Journal:	Br J Cancer. 2003 Sep 1;89(5):899-906.
Title:	Different mechanisms are implicated in ERBB2 gene overexpression in breast and in other cancers.
Author:	Vernimmen, D\|Gueders, M\|Pisvin, S\|Delvenne, P\|Winkler, R
PMID:	12942124

63.
Journal:	Clin Cancer Res. 2003 Sep 15;9(11):4221-6.
Title:	Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts.
Author:	Bockhorn, Maximilian\|Tsuzuki, Yoshikazu\|Xu, Lei\|Frilling, Andreja\|Broelsch, Christoph E\|Fukumura, Dai
PMID:	14519649

64.
Journal:	Nature. 2003 Oct 23;425(6960):851-6.
Title:	Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.
Author:	Thayer, Sarah P\|di Magliano, Marina Pasca\|Heiser, Patrick W\|Nielsen, Corinne M\|Roberts, Drucilla J\|Lauwers, Gregory Y\|Qi, Yan Ping\|Gysin, Stephan\|Fernandez-del Castillo, Carlos\|Yajnik, Vijay\|Antoniu, Bozena\|McMahon, Martin\|Warshaw, Andrew L\|Hebrok, Matthi
PMID:	14520413

65.
Journal:	Oncogene. 2003 Oct 30;22(49):7781-95.
Title:	Autocrine-mediated ErbB-2 kinase activation of STAT3 is required for growth factor independence of pancreatic cancer cell lines.
Author:	DeArmond, Daniel\|Brattain, Michael G\|Jessup, John Milburn\|Kreisberg, Jeffrey\|Malik, Shazli\|Zhao, Shujie\|Freeman, James W
PMID:	14586404

66.
Journal:	Br J Cancer. 2003 Dec 1;89(11):2110-5.
Title:	Incidence, mechanism and prognostic value of activated AKT in pancreas cancer.
Author:	Schlieman, M G\|Fahy, B N\|Ramsamooj, R\|Beckett, L\|Bold, R J
PMID:	14647146

67.
Journal:	Scand J Gastroenterol Suppl. 2003;(239):94-9.
Title:	Surveillance for familial pancreatic cancer.
Author:	de Vos tot Nederveen Cappel, W H\|Lagendijk, M A C\|Lamers, C B H W\|Morreau, H\|Vasen, H F A
PMID:	14743890

68.
Journal:	Cancer Res. 2004 Jan 15;64(2):622-30.
Title:	Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis.
Author:	Singh, Ajay P\|Moniaux, Nicolas\|Chauhan, Subhash C\|Meza, Jane L\|Batra, Surinder K
PMID:	14744777

69.
Journal:	Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2004 Feb;26(1):79-82.
Title:	[Recent advances in gene change of pancreatic cancer].
Author:	Wang, Yu-yue\|Cui, Quan-cai
PMID:	15052782

70.
Journal:	Hepatogastroenterology. 2004 Mar-Apr;51(56):334-7.
Title:	Correlation of immunohistochemically detected HER-2/neu (c-erbB-2) with histological stage and perineural invasion in pancreatic cancer.
Author:	Tamiolakis, D\|Venizelos, I\|Simopoulos, C\|Kotini, A\|Jivannakis, T\|Papadopoulos, N
PMID:	15086152

71.
Journal:	Am J Surg Pathol. 2004 Jun;28(6):813-20.
Title:	Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules.
Author:	van Eeden, Susanne\|de Leng, Wendy W J\|Offerhaus, G Johan A\|Morsink, Folkert H\|Weterman, Marian A J\|de Krijger, Ronald R\|Kloppel, Gunter\|Klimstra, David S
PMID:	15166675

72.
Journal:	Oncogene. 2004 Jul 29;23(34):5729-38.
Title:	A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
Author:	Jonckheere, Nicolas\|Perrais, Michael\|Mariette, Christophe\|Batra, Surinder K\|Aubert, Jean-Pierre\|Pigny, Pascal\|Van Seuningen, Isabelle
PMID:	15184872

73.
Journal:	Int J Oncol. 2004 Sep;25(3):765-70.
Title:	Identification and characterization of human DFNA5L, mouse Dfna5l, and rat Dfna5l genes in silico.
Author:	Katoh, Masuko\|Katoh, Masaru
PMID:	15289881

74.
Journal:	Oncol Rep. 2004 Dec;12(6):1309-15.
Title:	ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
Author:	Standop, Jens\|Schneider, Matthias\|Ulrich, Alexis\|Mathiak, Guenther\|Brand, Randall E\|Buechler, Markus W\|Pour, Parviz M
PMID:	15547756

75.
Journal:	Cancer Invest. 2004;22(5):706-12.
Title:	Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.
Author:	Safran, Howard\|Iannitti, David\|Ramanathan, Ramesh\|Schwartz, Jonathan D\|Steinhoff, Margaret\|Nauman, Chris\|Hesketh, Paul\|Rathore, Ritesh\|Wolff, Robert\|Tantravahi, Umadevi\|Hughes, T Marilyn\|Maia, Chris\|Pasquariello, Terry\|Goldstein, Lisa\|King, Thomas\|Tsai, J
PMID:	15581051

76.
Journal:	J Gastrointest Surg. 2004 Dec;8(8):960-9; discussion 969-70.
Title:	Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells.
Author:	Arnoletti, J Pablo\|Buchsbaum, Donald J\|Huang, Zhi-qiang\|Hawkins, Ashley E\|Khazaeli, Muhamad B\|Kraus, Matthias H\|Vickers, Selwyn M
PMID:	15585383

77.
Journal:	Clin Cancer Res. 2004 Dec 1;10(23):7834-41.
Title:	Targeting of HER2 antigen for the treatment of disseminated peritoneal disease.
Author:	Milenic, Diane E\|Garmestani, Kayhan\|Brady, Erik D\|Albert, Paul S\|Ma, Dangshe\|Abdulla, Alia\|Brechbiel, Martin W
PMID:	15585615

78.
Journal:
Title:	[(11)C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine
Author:	Shan, Liang
PMID:	20641864

79.
Journal:	Cancer Detect Prev. 2005;29(1):8-14.
Title:	Osteoclast-like giant cell tumor in mucinous cystadenocarcinoma of the pancreas: an immunohistochemical and molecular analysis.
Author:	Sedivy, Roland\|Kalipciyan, Maria\|Mazal, Peter R\|Wolf, Brigitte\|Wrba, F\|Karner-Hanusch, Judith\|Muhlbacher, Ferdinand\|Mader, Robert M
PMID:	15734212

80.
Journal:	Am J Clin Pathol. 2005 Jan;123(1):28-35.
Title:	A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
Author:	Hansel, Donna E\|Ashfaq, Raheela\|Rahman, Ayman\|Wanzer, Dana\|Yeo, Charles J\|Wilentz, Robb E\|Maitra, Anirban
PMID:	15762277

81.
Journal:	Pancreatology. 2005;5(1):44-58. Epub 2005 Mar 15.
Title:	ErbB2 growth factor receptor, a marker for neuroendocrine cells?
Author:	Standop, Jens\|Andrianifahanana, Mahefatiana\|Moniaux, Nicolas\|Schneider, Matthias\|Ulrich, Alexis\|Brand, Randall E\|Wisecarver, James L\|Bridge, Julia A\|Buchler, Markus W\|Adrian, Thomas E\|Batra, Surinder K\|Pour, Parviz M
PMID:	15775699

82.
Journal:	BMC Gastroenterol. 2005 Mar 31;5:12.
Title:	Epidermal growth factor mediates detachment from and invasion through collagen I and Matrigel in Capan-1 pancreatic cancer cells.
Author:	Shirk, Andrew J\|Kuver, Rahul
PMID:	15801978

83.
Journal:	Histochem Cell Biol. 2005 Mar;123(3):229-38.
Title:	Human archival tissues provide a valuable source for the analysis of spatial genome organization.
Author:	Wiech, Thorsten\|Timme, Sylvia\|Riede, Florian\|Stein, Stefan\|Schuricke, Michael\|Cremer, Christoph\|Werner, Martin\|Hausmann, Michael\|Walch, Axel
PMID:	15827756

84.
Journal:	Curr Drug Targets. 2005 May;6(3):259-74.
Title:	Small molecules with EGFR-TK inhibitor activity.
Author:	Albanell, Joan\|Gascon, Pere
PMID:	15857287

85.
Journal:	Gastroenterol Clin Biol. 2005 Apr;29(4):465-8.
Title:	From pancreatic intraepithelial neoplasia to cancer: a dramatic progression with K-ras status analysis.
Author:	Fernandez, Carla\|Chetaille, Bruno\|Tasei, Anne-Marie\|Sastre, Bernard\|Sahel, Jose\|Payan-Defais, Marie-Jose
PMID:	15864214

86.
Journal:	Int J Gastrointest Cancer. 2005;35(2):111-9.
Title:	Biological similarities and differences between pancreatic intraepithelial neoplasias and intraductal papillary mucinous neoplasms.
Author:	Moriya, Toshiyuki\|Kimura, Wataru\|Semba, Shuho\|Sakurai, Fumiaki\|Hirai, Ichiro\|Ma, Jinfeng\|Fuse, Akira\|Maeda, Kunihiko\|Yamakawa, Mitsunori
PMID:	15879625

87.
Journal:	Breast Cancer Res. 2005;7(4):R394-401. Epub 2005 Mar 24.
Title:	Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2.
Author:	Cicenas, Jonas\|Urban, Patrick\|Vuaroqueaux, Vincent\|Labuhn, Martin\|Kung, Willy\|Wight, Edward\|Mayhew, Mark\|Eppenberger, Urs\|Eppenberger-Castori, Serenella
PMID:	15987444

88.
Journal:	Int J Oncol. 2005 Oct;27(4):1125-30.
Title:	Combination therapy for advanced pancreatic cancer using Herceptin plus chemotherapy.
Author:	Buchler, Peter\|Reber, Howard A\|Eibl, Guido\|Roth, Mendel A\|Buchler, Markus W\|Friess, Helmut\|Isacoff, William H\|Hines, Oscar J
PMID:	16142331

89.
Journal:	Eur J Cancer. 2005 Oct;41(15):2213-36.
Title:	Molecular prognostic markers in pancreatic cancer: a systematic review.
Author:	Garcea, G\|Neal, C P\|Pattenden, C J\|Steward, W P\|Berry, D P
PMID:	16146690

90.
Journal:	Semin Radiat Oncol. 2005 Oct;15(4):254-64.
Title:	Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects.
Author:	Adsay, Nazmi Volkan\|Basturk, Olca\|Cheng, Jeanette D\|Andea, Aleodor A
PMID:	16183479

91.
Journal:	Cancer Biother Radiopharm. 2005 Oct;20(5):557-68.
Title:	Alpha-particle radioimmunotherapy of disseminated peritoneal disease using a (212)Pb-labeled radioimmunoconjugate targeting HER2.
Author:	Milenic, Diane E\|Garmestani, Kayhan\|Brady, Erik D\|Albert, Paul S\|Ma, Dangshe\|Abdulla, Alia\|Brechbiel, Martin W
PMID:	16248771

92.
Journal:	Mol Cancer Ther. 2005 Dec;4(12):1943-51.
Title:	Simultaneous targeting of the epidermal growth factor receptor and cyclooxygenase-2 pathways for pancreatic cancer therapy.
Author:	Ali, Shadan\|El-Rayes, Basil F\|Sarkar, Fazlul H\|Philip, Philip A
PMID:	16373709

93.
Journal:	Cancer Immunol Immunother. 2006 Jan;55(1):31-8.
Title:	Release of iC3b from apoptotic tumor cells induces tolerance by binding to immature dendritic cells in vitro and in vivo.
Author:	Schmidt, Jan\|Klempp, Christoph\|Buchler, Markus W\|Marten, Angela
PMID:	15891882

94.
Journal:	J Med Chem. 2006 Feb 23;49(4):1475-85.
Title:	Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors.
Author:	Klutchko, Sylvester R\|Zhou, Hairong\|Winters, R Thomas\|Tran, Tuan P\|Bridges, Alexander J\|Althaus, Irene W\|Amato, Danielle M\|Elliott, William L\|Ellis, Paul A\|Meade, Mary Ann\|Roberts, Billy J\|Fry, David W\|Gonzales, Andrea J\|Harvey, Patricia J\|Nelson, James M
PMID:	16480284

95.
Journal:	World J Gastroenterol. 2006 Jan 21;12(3):437-42.
Title:	Differential c-erbB-1 and c-erbB-2 mRNA expression in cancer of the pancreas compared with cancer of the papilla of Vater.
Author:	Prenzel, Klaus L\|Warnecke-Eberz, Ute\|Brabender, Jan\|Baldus, Stephan E\|Bollschweiler, Elfriede\|Gutschow, Christian A\|Drebber, Uta\|Hoelscher, Arnulf H\|Schneider, Paul M
PMID:	16489645

96.
Journal:	Med Sci Monit. 2006 Sep;12(9):RA186-93.
Title:	Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
Author:	Talar-Wojnarowska, Renata\|Malecka-Panas, Ewa
PMID:	16940943

97.
Journal:	Int J Cancer. 2007 Feb 1;120(3):514-23.
Title:	Expression and differential signaling of heregulins in pancreatic cancer cells.
Author:	Kolb, Armin\|Kleeff, Jorg\|Arnold, Nichole\|Giese, Nathalia A\|Giese, Thomas\|Korc, Murray\|Friess, Helmut
PMID:	17096356

98.
Journal:	Cancer Res. 2007 Jan 15;67(2):433-6.
Title:	Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy.
Author:	Singh, Ajay P\|Chaturvedi, Pallavi\|Batra, Surinder K
PMID:	17234748

99.
Journal:	Zhonghua Bing Li Xue Za Zhi. 2007 Feb;36(2):102-6.
Title:	[Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
Author:	Liang, Zhi-Yong\|Wang, Wen-Ze\|Gao, Jie\|Wu, Sha-Fei\|Zeng, Xuan\|Liu, Tong-Hua
PMID:	17493384

100.
Journal:	Clin Cancer Res. 2007 Jun 1;13(11):3356-62.
Title:	In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Author:	Larbouret, Christel\|Robert, Bruno\|Navarro-Teulon, Isabelle\|Thezenas, Simon\|Ladjemi, Maha-Zohra\|Morisseau, Sebastien\|Campigna, Emmanuelle\|Bibeau, Frederic\|Mach, Jean-Pierre\|Pelegrin, Andre\|Azria, David
PMID:	17545543

101.
Journal:	Int J Cancer. 2007 Oct 1;121(7):1410-6.
Title:	Overexpression of ErbB2 in the exocrine pancreas induces an inflammatory response but not increased proliferation.
Author:	Algul, Hana\|Wagner, Martin\|Lesina, Marina\|Schmid, Roland M
PMID:	17546589

102.
Journal:	Oncol Rep. 2007 Aug;18(2):433-9.
Title:	Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.
Author:	Saeki, Hiroyuki\|Yanoma, Shunsuke\|Takemiya, Shouji\|Sugimasa, Yukio\|Akaike, Makoto\|Yukawa, Norio\|Rino, Yasushi\|Imada, Toshio
PMID:	17611667

103.
Journal:	Cancer Res. 2007 Aug 1;67(15):7256-65.
Title:	Epidermal growth factor receptor tyrosine phosphorylation and signaling controlled by a nuclear receptor coactivator, amplified in breast cancer 1.
Author:	Lahusen, Tyler\|Fereshteh, Mark\|Oh, Annabell\|Wellstein, Anton\|Riegel, Anna T
PMID:	17671194

104.
Journal:	Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):299-304.
Title:	Histologic and immunohistochemical changes in the stented common bile duct.
Author:	Euscher, Elizabeth D\|Marsh, William L Jr\|Lucas, Joel G\|Frankel, Wendy L
PMID:	17721275

105.
Journal:	Med Sci (Paris). 2007 Oct;23(10):800-3.
Title:	[Combined anti-EGFR and anti-HER2 monoclonal antibodies: preclinical efficacy in the treatment of pancreatic cancer].
Author:	Larbouret, Christel\|Robert, Bruno\|Teulon, Isabelle\|Azria, David\|Pelegrin, Andre
PMID:	17937885

106.
Journal:	Bull Cancer. 2007 Oct;94(10):860-2.
Title:	[Combination of anti-EGFR and anti-HER2 antibodies: hope in pancreatic cancer treatment].
Author:	Larbouret, Christel\|Robert, Bruno\|Teulon, Isabelle\|Assenat, Eric\|Azria, David\|Pelegrin, Andre
PMID:	17964979

107.
Journal:	Fam Cancer. 2008;7(1):103-12. Epub 2007 Nov 9.
Title:	Pancreatic cancer and the FAMMM syndrome.
Author:	Lynch, Henry T\|Fusaro, Ramon M\|Lynch, Jane F\|Brand, Randall
PMID:	17992582

108.
Journal:	Biochem Pharmacol. 2008 Feb 15;75(4):836-46.
Title:	The immunocytokine scFv23/TNF targeting HER-2/neu induces synergistic cytotoxic effects with 5-fluorouracil in TNF-resistant pancreatic cancer cell lines.
Author:	Lyu, Mi-Ae\|Kurzrock, Razelle\|Rosenblum, Michael G
PMID:	18082672

109.
Journal:	Clin Chem. 2008 Mar;54(3):582-9.
Title:	Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Author:	Fredriksson, Simon\|Horecka, Joe\|Brustugun, Odd Terje\|Schlingemann, Joerg\|Koong, Albert C\|Tibshirani, Rob\|Davis, Ronald W
PMID:	18171715

110.
Journal:	Gan To Kagaku Ryoho. 2008 Feb;35(2):351-60.
Title:	[Future directions of anticancer drug development in Japan].
Author:	Akaza, Hideyuki\|Kawai, Koji\|Tsuruo, Takashi\|Tsukagoshi, Shigeru\|Aiba, Keisuke\|Shimada, Yasuhiro\|Kakeji, Yoshihiro\|Ishikawa, Hideki\|Ikeda, Tadashi\|Nakamura, Seigo\|Tamura, Tomohide\|Yamamoto, Nobuyuki\|Isonishi, Seiji\|Hinotsu, Shiro\|Hirose, Masaru\|Katsura, Ju
PMID:	18281781

111.
Journal:	Cancer Res. 2008 Apr 1;68(7):2065-70.
Title:	MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.
Author:	Chaturvedi, Pallavi\|Singh, Ajay P\|Chakraborty, Subhankar\|Chauhan, Subhash C\|Bafna, Sangeeta\|Meza, Jane L\|Singh, Pankaj K\|Hollingsworth, Michael A\|Mehta, Parmender P\|Batra, Surinder K
PMID:	18381409

112.
Journal:	Dig Dis Sci. 2008 Nov;53(11):3026-32.
Title:	HER2 gene amplification and chromosome 17 copy number do not predict survival of patients with resected pancreatic adenocarcinoma.
Author:	Sharif, Saima\|Ramanathan, Ramesh K\|Potter, Douglas\|Cieply, Kathleen\|Krasinskas, Alyssa M
PMID:	18463983

113.
Journal:	FASEB J. 2008 Aug;22(8):3035-45.
Title:	Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases.
Author:	Vincent, Audrey\|Ducourouble, Marie-Paule\|Van Seuningen, Isabelle
PMID:	18492726

114.
Journal:	Anticancer Res. 2008 Mar-Apr;28(2B):1399-404.
Title:	Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
Author:	Pryczynicz, Anna\|Guzinska-Ustymowicz, Katarzyna\|Kemona, Andrzej\|Czyzewska, Jolanta
PMID:	18505086

115.
Journal:	J Immunother. 2008 Jul-Aug;31(6):537-44.
Title:	Antitumor efficacy of trastuzumab in nude mice orthotopically xenografted with human pancreatic tumor cells expressing low levels of HER-2/neu.
Author:	Pratesi, Graziella\|Petrangolini, Giovanna\|Tortoreto, Monica\|Addis, Alessandro\|Zunino, Franco\|Calcaterra, Claudia\|Merlo, Andrea\|Tagliabue, Elda\|Menard, Sylvie\|Balsari, Andrea
PMID:	18528301

116.
Journal:	Eur J Gastroenterol Hepatol. 2008 Aug;20(8):713-5.
Title:	Pancreatic cancer: a plea for good and comprehensive morphological studies.
Author:	Algul, Hana\|Schmid, Roland M
PMID:	18617774

117.
Journal:	Cancer Genomics Proteomics. 2008 May-Aug;5(3-4):161-8.
Title:	Phosphoproteome and transcriptome analyses of ErbB ligand-stimulated MCF-7 cells.
Author:	Nagashima, Takeshi\|Oyama, Masaaki\|Kozuka-Hata, Hiroko\|Yumoto, Noriko\|Sakaki, Yoshiyuki\|Hatakeyama, Mariko
PMID:	18820370

118.
Journal:	Cancer Res. 2008 Nov 1;68(21):8938-44.
Title:	Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Author:	Sung, Bokyung\|Jhurani, Sonia\|Ahn, Kwang Seok\|Mastuo, Yoichi\|Yi, Tingfang\|Guha, Sushovan\|Liu, Mingyao\|Aggarwal, Bharat B
PMID:	18974138

119.
Journal:	Appl Immunohistochem Mol Morphol. 2009 Jan;17(1):31-9.
Title:	Histologic, immunohistochemical, and molecular classification of 52 IPMNs of the pancreas.
Author:	Chadwick, Barbara\|Willmore-Payne, Carlynn\|Tripp, Sheryl\|Layfield, Lester J\|Hirschowitz, Sharon\|Holden, Joseph
PMID:	18813127

120.
Journal:	J Biol Chem. 2009 Jan 16;284(3):1385-93.
Title:	The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells.
Author:	Zhao, Yingshe\|Min, Chengyin\|Vora, Siddharth R\|Trackman, Philip C\|Sonenshein, Gail E\|Kirsch, Kathrin H
PMID:	19029090

121.
Journal:	BMC Surg. 2009 Jan 8;9:1.
Title:	A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer.
Author:	Mihaljevic, Andre\|Buchler, Peter\|Harder, Jan\|Hofheinz, Ralf\|Gregor, Michael\|Kanzler, Stephan\|Schmiegel, Wolff\|Heinemann, Volker\|Endlicher, Esther\|Kloppel, Gunter\|Seufferlein, Thomas\|Geissler, Michael
PMID:	19133157

122.
Journal:	Clin Cancer Res. 2009 Feb 1;15(3):924-32.
Title:	A novel human Her-2/neu chimeric molecule expressed by Listeria monocytogenes can elicit potent HLA-A2 restricted CD8-positive T cell responses and impact the growth and spread of Her-2/neu-positive breast tumors.
Author:	Seavey, Matthew M\|Pan, Zhen-Kun\|Maciag, Paulo C\|Wallecha, Anu\|Rivera, Sandra\|Paterson, Yvonne\|Shahabi, Vafa
PMID:	19188163

123.
Journal:	Cancer Res. 2009 Apr 1;69(7):2950-5.
Title:	Associations between selected biomarkers and prognosis in a population-based pancreatic cancer tissue microarray.
Author:	Takikita, Mikiko\|Altekruse, Sean\|Lynch, Charles F\|Goodman, Mark T\|Hernandez, Brenda Y\|Green, Mark\|Cozen, Wendy\|Cockburn, Myles\|Sibug Saber, Maria\|Topor, Marie\|Zeruto, Chris\|Abedi-Ardekani, Behnoush\|Reichman, Marsha E\|Hewitt, Stephen M
PMID:	19276352

124.
Journal:	Cancer Sci. 2009 Jul;100(7):1243-7.
Title:	HER2 overexpression correlates with survival after curative resection of pancreatic cancer.
Author:	Komoto, Masahiro\|Nakata, Bunzo\|Amano, Ryosuke\|Yamada, Nobuya\|Yashiro, Masakazu\|Ohira, Masaichi\|Wakasa, Kenichi\|Hirakawa, Kosei
PMID:	19432892

125.
Journal:	Mol Cancer Ther. 2009 May;8(5):1207-17.
Title:	The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
Author:	Liu, Xinyi\|Abdelrahim, Maen\|Abudayyeh, Ala\|Lei, Ping\|Safe, Stephen
PMID:	19435870

126.
Journal:	JOP. 2009 Jul 6;10(4):357-60.
Title:	Pharmacogenetics in pancreatic cancer. Highlights from the 45th ASCO annual meeting. Orlando, FL, USA. May 29-June 2, 2009.
Author:	Strimpakos, Alexios S\|Syrigos, Kostas N\|Saif, Muhammad Wasif
PMID:	19581734

127.
Journal:	Mayo Clin Proc. 2009 Sep;84(9):801-10.
Title:	Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas.
Author:	Dewald, Gordon W\|Smyrk, Thomas C\|Thorland, Erik C\|McWilliams, Robert R\|Van Dyke, Daniel L\|Keefe, Jeannette G\|Belongie, Kimberly J\|Smoley, Stephanie A\|Knutson, Darlene L\|Fink, Stephanie R\|Wiktor, Anne E\|Petersen, Gloria M
PMID:	19720778

128.
Journal:	Br J Cancer. 2009 Oct 6;101(7):1155-61.
Title:	Pancreatic cancer cells resistance to gemcitabine: the role of MUC4 mucin.
Author:	Bafna, S\|Kaur, S\|Momi, N\|Batra, S K
PMID:	19738614

129.
Journal:	Immunotherapy. 2009 Mar;1(2):223-9.
Title:	Monoclonal antibodies in the treatment of pancreatic cancer.
Author:	Huang, Zhi-Qiang\|Buchsbaum, Donald J
PMID:	20046965

130.
Journal:	Folia Histochem Cytobiol. 2009;47(4):667-71.
Title:	Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
Author:	Pryczynicz, Anna\|Guzinska-Ustymowicz, Katarzyna\|Czyzewska, Jolanta\|Kemona, Andrzej
PMID:	20430737

131.
Journal:	Ann Oncol. 2010 Jan;21(1):98-103.
Title:	Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts.
Author:	Larbouret, C\|Robert, B\|Bascoul-Mollevi, C\|Penault-Llorca, F\|Ho-Pun-Cheung, A\|Morisseau, S\|Navarro-Teulon, I\|Mach, J-P\|Pelegrin, A\|Azria, D
PMID:	19889608

132.
Journal:	Cancer Sci. 2010 Feb;101(2):468-73.
Title:	In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer.
Author:	Komoto, Masahiro\|Nakata, Bunzo\|Nishii, Takafumi\|Kawajiri, Hidemi\|Shinto, Osamu\|Amano, Ryosuke\|Yamada, Nobuya\|Yashiro, Masakazu\|Hirakawa, Kosei
PMID:	19925494

133.
Journal:	Clin Cancer Res. 2010 Feb 1;16(3):912-23.
Title:	Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status.
Author:	Kimple, Randall J\|Vaseva, Angelina V\|Cox, Adrienne D\|Baerman, Kathryn M\|Calvo, Benjamin F\|Tepper, Joel E\|Shields, Janiel M\|Sartor, Carolyn I
PMID:	20103665

134.
Journal:	Biochim Biophys Acta. 2010 Apr;1803(4):435-42.
Title:	Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells.
Author:	Lang, Sven A\|Hackl, Christina\|Moser, Christian\|Fichtner-Feigl, Stefan\|Koehl, Gudrun E\|Schlitt, Hans J\|Geissler, Edward K\|Stoeltzing, Oliver
PMID:	20116405

135.
Journal:	J Med Chem. 2010 Mar 11;53(5):2000-9.
Title:	Discovery of 7-(4-(3-ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDc-101) as a potent multi-acting HDAC, EGFR, and HER2 inhibitor for the treatment of cancer.
Author:	Cai, Xiong\|Zhai, Hai-Xiao\|Wang, Jing\|Forrester, Jeffrey\|Qu, Hui\|Yin, Ling\|Lai, Cheng-Jung\|Bao, Rudi\|Qian, Changgeng
PMID:	20143778

136.
Journal:	Histopathology. 2010 Mar;56(4):440-8.
Title:	Expression of L1CAM, COX-2, EGFR, c-KIT and Her2/neu in anaplastic pancreatic cancer: putative therapeutic targets?
Author:	Bergmann, Frank\|Moldenhauer, Gerhard\|Herpel, Esther\|Gaida, Matthias M\|Strobel, Oliver\|Werner, Jens\|Esposito, Irene\|Muerkoster, Susanne Sebens\|Schirmacher, Peter\|Kern, Michael A
PMID:	20459551

137.
Journal:	Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2273-82.
Title:	Cistaceae aqueous extracts containing ellagitannins show antioxidant and antimicrobial capacity, and cytotoxic activity against human cancer cells.
Author:	Barrajon-Catalan, Enrique\|Fernandez-Arroyo, Salvador\|Saura, Domingo\|Guillen, Emilio\|Fernandez-Gutierrez, Alberto\|Segura-Carretero, Antonio\|Micol, Vicente
PMID:	20510328

138.
Journal:	Dis Markers. 2010;28(4):241-51.
Title:	Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications.
Author:	Omenn, Gilbert S\|Yocum, Anastasia K\|Menon, Rajasree
PMID:	20534909

139.
Journal:	Biochem Pharmacol. 2010 Nov 15;80(10):1553-62.
Title:	Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-kappaB activation in breast and pancreatic tumor cells.
Author:	Chua, Angeline Wei Ling\|Hay, Hui Sin\|Rajendran, Peramaiyan\|Shanmugam, Muthu K\|Li, Feng\|Bist, Pradeep\|Koay, Evelyn S C\|Lim, Lina H K\|Kumar, Alan Prem\|Sethi, Gautam
PMID:	20699088

140.
Journal:	J Cell Biochem. 2010 Dec 1;111(5):1160-8.
Title:	Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis.
Author:	Min, Chengyin\|Zhao, Yingshe\|Romagnoli, Mathilde\|Trackman, Philip C\|Sonenshein, Gail E\|Kirsch, Kathrin H
PMID:	20717927

141.
Journal:	J Mol Med (Berl). 2010 Dec;88(12):1243-53.
Title:	Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor.
Author:	Yadav, Vivek R\|Sung, Bokyung\|Prasad, Sahdeo\|Kannappan, Ramaswamy\|Cho, Sung-Gook\|Liu, Mingyao\|Chaturvedi, Madan M\|Aggarwal, Bharat B
PMID:	20798912

142.
Journal:	Am J Pathol. 2010 Nov;177(5):2323-33.
Title:	Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis.
Author:	Stein, Torsten\|Cosimo, Emilio\|Yu, Xinzi\|Smith, Paul R\|Simon, Ronald\|Cottrell, Lorna\|Pringle, Marie-Anne\|Bell, Alexandra K\|Lattanzio, Laura\|Sauter, Guido\|Lo Nigro, Cristiana\|Crook, Timothy\|Machesky, Laura M\|Gusterson, Barry A
PMID:	20847288

143.
Journal:	Cancer Gene Ther. 2011 Jan;18(1):53-62.
Title:	Development of a live and highly attenuated Listeria monocytogenes-based vaccine for the treatment of Her2/neu-overexpressing cancers in human.
Author:	Shahabi, V\|Seavey, M M\|Maciag, P C\|Rivera, S\|Wallecha, A
PMID:	20725099

144.
Journal:	Exp Cell Res. 2011 Feb 15;317(4):392-404.
Title:	Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines.
Author:	Mill, Christopher P\|Gettinger, Kathleen L\|Riese, David J 2nd
PMID:	21110957

145.
Journal:	Bioorg Med Chem. 2011 Jan 1;19(1):67-76.
Title:	Synthesis of a covalent gemcitabine-(carbamate)-[anti-HER2/neu] immunochemotherapeutic and its cytotoxic anti-neoplastic activity against chemotherapeutic-resistant SKBr-3 mammary carcinoma.
Author:	Coyne, C P\|Jones, Toni\|Pharr, Todd
PMID:	21169024

146.
Journal:	J Immunol. 2011 Apr 1;186(7):4067-77.
Title:	A novel tumor-associated pancreatic glycoprotein is internalized by human dendritic cells and induces their maturation.
Author:	Franceschi, Cecile\|Collignon, Aurelie\|Isnardon, Daniel\|Benkoel, Liliane\|Verine, Alain\|Silvy, Francoise\|Bernard, Jean-Paul\|Lombardo, Dominique\|Beraud, Evelyne\|Olive, Daniel\|Mas, Eric
PMID:	21346236

147.
Journal:	Cancer Lett. 2011 Jul 28;306(2):180-9.
Title:	RNAi knockdown of Hop (Hsp70/Hsp90 organising protein) decreases invasion via MMP-2 down regulation.
Author:	Walsh, Naomi\|Larkin, AnneMarie\|Swan, Niall\|Conlon, Kevin\|Dowling, Paul\|McDermott, Ray\|Clynes, Martin
PMID:	21470770

148.
Journal:	Nanomedicine. 2011 Dec;7(6):859-70.
Title:	Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy.
Author:	Arya, Geetanjali\|Vandana, Mallaredy\|Acharya, Sarbari\|Sahoo, Sanjeeb K
PMID:	21550422

149.
Journal:	Free Radic Biol Med. 2011 Sep 15;51(6):1164-74.
Title:	Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway.
Author:	Shin-Kang, Sonyo\|Ramsauer, Victoria P\|Lightner, Janet\|Chakraborty, Kanishka\|Stone, William\|Campbell, Sharon\|Reddy, Shrikanth A G\|Krishnan, Koyamangalath
PMID:	21723941

150.
Journal:	J Vis Exp. 2011 Oct 25;(56):e3334.
Title:	Heterogeneity mapping of protein expression in tumors using quantitative immunofluorescence.
Author:	Faratian, Dana\|Christiansen, Jason\|Gustavson, Mark\|Jones, Christine\|Scott, Christopher\|Um, InHwa\|Harrison, David J
PMID:	22064683

151.
Journal:	Oncol Lett. 2011 Jan;2(1):161-166.
Title:	Ductal adenocarcinoma of the pancreas: Expression of growth factor receptors, oncogenes and suppressor genes, and their relationship to pathological features, staging and survival.
Author:	Lozano-Leon, Antonio\|Perez-Quintela, Begona Vieites\|Iglesias-Garcia, Julio\|Larino-Noia, Jose\|Varo, Evaristo\|Forteza, Jeronimo\|Dominguez-Munoz, J Enrique
PMID:	22870146

152.
Journal:	Am J Clin Oncol. 2011 Feb;34(1):50-2.
Title:	Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II study.
Author:	Safran, Howard\|Miner, Thomas\|Bahary, Nathan\|Whiting, Sam\|Lopez, Charles D\|Sun, Weijing\|Charpentier, Kevin\|Shipley, Joshua\|Anderson, Elliot\|McNulty, Brendan\|Schumacher, Andrew\|Clark, Alessandra\|Vakharia, Jamsheed\|Kennedy, Teresa\|Sio, Terence
PMID:	24757739

153.
Journal:	Mol Cancer Ther. 2012 Jan;11(1):24-33.
Title:	MUC13 mucin augments pancreatic tumorigenesis.
Author:	Chauhan, Subhash C\|Ebeling, Mara C\|Maher, Diane M\|Koch, Michael D\|Watanabe, Akira\|Aburatani, Hiroyuki\|Lio, Yuhlong\|Jaggi, Meena
PMID:	22027689

154.
Journal:	J Cell Physiol. 2012 Oct;227(10):3381-8.
Title:	Novel anti-ErbB3 monoclonal antibodies show therapeutic efficacy in xenografted and spontaneous mouse tumors.
Author:	Aurisicchio, Luigi\|Marra, Emanuele\|Luberto, Laura\|Carlomosti, Fabrizio\|De Vitis, Claudia\|Noto, Alessia\|Gunes, Zeynep\|Roscilli, Giuseppe\|Mesiti, Giuseppe\|Mancini, Rita\|Alimandi, Maurizio\|Ciliberto, Gennaro
PMID:	22213458

155.
Journal:	Br J Cancer. 2012 Mar 13;106(6):1033-8.
Title:	Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer.
Author:	Harder, J\|Ihorst, G\|Heinemann, V\|Hofheinz, R\|Moehler, M\|Buechler, P\|Kloeppel, G\|Rocken, C\|Bitzer, M\|Boeck, S\|Endlicher, E\|Reinacher-Schick, A\|Schmoor, C\|Geissler, M
PMID:	22374460

156.
Journal:	PLoS One. 2012;7(2):e32232.
Title:	The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways.
Author:	Jonckheere, Nicolas\|Skrypek, Nicolas\|Merlin, Johann\|Dessein, Anne Frederique\|Dumont, Patrick\|Leteurtre, Emmanuelle\|Harris, Ann\|Desseyn, Jean-Luc\|Susini, Christiane\|Frenois, Frederic\|Van Seuningen, Isabelle
PMID:	22393391

157.
Journal:	Neoplasia. 2012 Feb;14(2):121-30.
Title:	In pancreatic carcinoma, dual EGFR/HER2 targeting with cetuximab/trastuzumab is more effective than treatment with trastuzumab/erlotinib or lapatinib alone: implication of receptors' down-regulation and dimers' disruption.
Author:	Larbouret, Christel\|Gaborit, Nadege\|Chardes, Thierry\|Coelho, Mickael\|Campigna, Emmanuelle\|Bascoul-Mollevi, Caroline\|Mach, Jean-Pierre\|Azria, David\|Robert, Bruno\|Pelegrin, Andre
PMID:	22431920

158.
Journal:	Curr Drug Targets. 2012 Jun;13(6):802-10.
Title:	Targeting EGFR in pancreatic cancer treatment.
Author:	Troiani, T\|Martinelli, E\|Capasso, A\|Morgillo, F\|Orditura, Michele\|De Vita, F\|Ciardiello, F
PMID:	22458527

159.
Journal:	Cancer Res. 2012 May 15;72(10):2554-64.
Title:	KRas induces a Src/PEAK1/ErbB2 kinase amplification loop that drives metastatic growth and therapy resistance in pancreatic cancer.
Author:	Kelber, Jonathan A\|Reno, Theresa\|Kaushal, Sharmeela\|Metildi, Cristina\|Wright, Tracy\|Stoletov, Konstantin\|Weems, Jessica M\|Park, Frederick D\|Mose, Evangeline\|Wang, Yingchun\|Hoffman, Robert M\|Lowy, Andrew M\|Bouvet, Michael\|Klemke, Richard L
PMID:	22589274

160.
Journal:	BMC Med Genet. 2012 May 29;13:41.
Title:	Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study.
Author:	Rummel, Seth\|Shriver, Craig D\|Ellsworth, Rachel E
PMID:	22642827

161.
Journal:	PLoS One. 2012;7(6):e39684.
Title:	Concomitant targeting of EGF receptor, TGF-beta and SRC points to a novel therapeutic approach in pancreatic cancer.
Author:	Deharvengt, Sophie\|Marmarelis, Melina\|Korc, Murray
PMID:	22761868

162.
Journal:	Oncol Rep. 2012 Dec;28(6):2211-6.
Title:	Dual ErbB1 and ErbB2 receptor tyrosine kinase inhibition exerts synergistic effect with conventional chemotherapy in pancreatic cancer.
Author:	Singla, Smit\|Pippin, James A\|Drebin, Jeffrey A
PMID:	23007710

163.
Journal:	Coll Antropol. 2012 Sep;36(3):1063-7.
Title:	Etiology and oncogenesis of pancreatic carcinoma.
Author:	Dobrila-Dintinjana, Renata\|Vanis, Nenad\|Dintinjana, Marijan\|Radic, Mladen
PMID:	23213974

164.
Journal:	Oncoimmunology. 2012 Nov 1;1(8):1387-1389.
Title:	CAR's made it to the pancreas.
Author:	Chmielewski, Markus\|Maliar, Amit\|Eshhar, Zelig\|Abken, Hinrich
PMID:	23243602

165.
Journal:	J Cancer Ther. 2012 Oct;3(5A):689-711.
Title:	Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.
Author:	Coyne, Cody P\|Jones, Toni\|Bear, Ryan
PMID:	26225216

166.
Journal:	Oncogene. 2013 Mar 14;32(11):1384-95.
Title:	Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through alpha7nAChR-mediated MUC4 upregulation.
Author:	Momi, N\|Ponnusamy, M P\|Kaur, S\|Rachagani, S\|Kunigal, S S\|Chellappan, S\|Ouellette, M M\|Batra, S K
PMID:	22614008

167.
Journal:	Invest New Drugs. 2013 Jun;31(3):558-66.
Title:	EGFR and HER2 inhibition in pancreatic cancer.
Author:	Walsh, Naomi\|Kennedy, Susan\|Larkin, AnneMarie\|Corkery, Brendan\|O'Driscoll, Lorraine\|Clynes, Martin\|Crown, John\|O'Donovan, Norma
PMID:	23076814

168.
Journal:	Pancreas. 2013 Apr;42(3):411-21.
Title:	Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
Author:	Gilbert, Judith A\|Adhikari, Laura J\|Lloyd, Ricardo V\|Halfdanarson, Thorvardur R\|Muders, Michael H\|Ames, Matthew M
PMID:	23211371

169.
Journal:	J Natl Cancer Inst. 2013 Feb 20;105(4):266-73.
Title:	HER3 overexpression and survival in solid tumors: a meta-analysis.
Author:	Ocana, Alberto\|Vera-Badillo, Francisco\|Seruga, Bostjan\|Templeton, Arnoud\|Pandiella, Atanasio\|Amir, Eitan
PMID:	23221996

170.
Journal:	Pancreas. 2013 Mar;42(2):216-22.
Title:	Genetic alterations of K-ras, p53, c-erbB-2, and DPC4 in pancreatic ductal adenocarcinoma and their correlation with patient survival.
Author:	Shin, Sang Hyun\|Kim, Song Cheol\|Hong, Seung-Mo\|Kim, Young Hoon\|Song, Ki-Byung\|Park, Kwang-Min\|Lee, Young-Joo
PMID:	23344532

171.
Journal:	World J Gastrointest Oncol. 2013 Jan 15;5(1):1-3.
Title:	Complexity of molecular alterations impacts pancreatic cancer prognosis.
Author:	Regel, Ivonne\|Kong, Bo\|Bruns, Philipp\|Michalski, Christoph W\|Kleeff, Jorg
PMID:	23355925

172.
Journal:	Cancer Res. 2013 Apr 1;73(7):2221-34.
Title:	Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals.
Author:	Miyabayashi, Koji\|Ijichi, Hideaki\|Mohri, Dai\|Tada, Motohisa\|Yamamoto, Keisuke\|Asaoka, Yoshinari\|Ikenoue, Tsuneo\|Tateishi, Keisuke\|Nakai, Yousuke\|Isayama, Hiroyuki\|Morishita, Yasuyuki\|Omata, Masao\|Moses, Harold L\|Koike, Kazuhiko
PMID:	23378339

173.
Journal:	Cancer Discov. 2013 Mar;3(3):280-93.
Title:	Outlier kinase expression by RNA sequencing as targets for precision therapy.
Author:	Kothari, Vishal\|Wei, Iris\|Shankar, Sunita\|Kalyana-Sundaram, Shanker\|Wang, Lidong\|Ma, Linda W\|Vats, Pankaj\|Grasso, Catherine S\|Robinson, Dan R\|Wu, Yi-Mi\|Cao, Xuhong\|Simeone, Diane M\|Chinnaiyan, Arul M\|Kumar-Sinha, Chandan
PMID:	23384775

174.
Journal:	Br J Cancer. 2013 Mar 19;108(5):1052-60.
Title:	Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer.
Author:	Miles, D W\|de Haas, S L\|Dirix, L Y\|Romieu, G\|Chan, A\|Pivot, X\|Tomczak, P\|Provencher, L\|Cortes, J\|Delmar, P R\|Scherer, S J
PMID:	23422754

175.
Journal:	Neoplasia. 2013 Feb;15(2):143-55.
Title:	Inhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinib.
Author:	Walters, Dustin M\|Lindberg, James M\|Adair, Sara J\|Newhook, Timothy E\|Cowan, Catharine R\|Stokes, Jayme B\|Borgman, Cheryl A\|Stelow, Edward B\|Lowrey, Bryce T\|Chopivsky, Maria E\|Gilmer, Tona M\|Parsons, John T\|Bauer, Todd W
PMID:	23441129

176.
Journal:	Cancer Lett. 2013 Oct 1;339(1):135-43.
Title:	The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Author:	Shen, Ruizhe\|Wang, Qi\|Cheng, Shidan\|Liu, Tingting\|Jiang, He\|Zhu, Jiaxing\|Wu, Yunlin\|Wang, Lifu
PMID:	23887057

177.
Journal:	Int J Pharm. 2013 Nov 1;456(1):202-11.
Title:	Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
Author:	Buckway, Brandon\|Wang, Yongjian\|Ray, Abhijit\|Ghandehari, Hamidreza
PMID:	23933441

178.
Journal:	Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15389-94.
Title:	Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2.
Author:	Maron, Ruth\|Schechter, Bilha\|Mancini, Maicol\|Mahlknecht, Georg\|Yarden, Yosef\|Sela, Michael
PMID:	24003140

179.
Journal:	Genome Med. 2013 Aug 31;5(8):78.
Title:	Clinical and molecular characterization of HER2 amplified-pancreatic cancer.
Author:	Chou, Angela\|Waddell, Nicola\|Cowley, Mark J\|Gill, Anthony J\|Chang, David K\|Patch, Ann-Marie\|Nones, Katia\|Wu, Jianmin\|Pinese, Mark\|Johns, Amber L\|Miller, David K\|Kassahn, Karin S\|Nagrial, Adnan M\|Wasan, Harpreet\|Goldstein, David\|Toon, Christopher W\|Chin, V
PMID:	24004612

180.
Journal:	Breast Cancer Res Treat. 2013 Nov;142(2):311-22.
Title:	Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
Author:	Tsang, Julia Y S\|Kwok, Ying Kin\|Chan, Kit Wing\|Ni, Yun-Bi\|Chow, Wan Ning Vanessa\|Lau, Kwok Fai\|Shao, Mu-Min\|Chan, Siu Ki\|Tan, Puay-Hoon\|Tse, Gary M
PMID:	24186057

181.
Journal:	J Cancer Res Ther Oncol. 2013 Aug 22;1(1):10.
Title:	Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant.
Author:	Gallo, Richard M\|Bryant, Ianthe N\|Mill, Christopher P\|Kaverman, Steven\|Riese, David J 2nd
PMID:	24791013

182.
Journal:	Macromol Biosci. 2014 Jan;14(1):92-9.
Title:	In vitro evaluation of HPMA-copolymers targeted to HER2 expressing pancreatic tumor cells for image guided drug delivery.
Author:	Buckway, Brandon\|Wang, Yongjian\|Ray, Abhijit\|Ghandehari, Hamidreza
PMID:	24038924

183.
Journal:	APMIS. 2014 Jun;122(6):476-81.
Title:	Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinoma.
Author:	Koperek, Oskar\|Aumayr, Klaus\|Schindl, Martin\|Werba, Gregor\|Soleiman, Afschin\|Schoppmann, Sebastian\|Sahora, Klaus\|Birner, Peter
PMID:	24164699

184.
Journal:	Clin Cancer Res. 2014 Feb 1;20(3):688-700.
Title:	MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-kappaB signaling in pancreatic cancer.
Author:	Kaur, Sukhwinder\|Sharma, Neil\|Krishn, Shiv Ram\|Lakshmanan, Imay\|Rachagani, Satyanarayana\|Baine, Michael J\|Smith, Lynette M\|Lele, Subodh M\|Sasson, Aaron R\|Guha, Sushovan\|Mallya, Kavita\|Anderson, Judy M\|Hollingsworth, Michael A\|Batra, Surinder K
PMID:	24240113

185.
Journal:	Pharmacol Res. 2014 Jan;79:34-74.
Title:	The ErbB/HER family of protein-tyrosine kinases and cancer.
Author:	Roskoski, Robert Jr
PMID:	24269963

186.
Journal:	Cancer Res. 2014 Mar 1;74(5):1349-60.
Title:	Novel bispecific antibodies increase gammadelta T-cell cytotoxicity against pancreatic cancer cells.
Author:	Oberg, Hans-Heinrich\|Peipp, Matthias\|Kellner, Christian\|Sebens, Susanne\|Krause, Sarah\|Petrick, Domantas\|Adam-Klages, Sabine\|Rocken, Christoph\|Becker, Thomas\|Vogel, Ilka\|Weisner, Dietrich\|Freitag-Wolf, Sandra\|Gramatzki, Martin\|Kabelitz, Dieter\|Wesch, Danie
PMID:	24448235

187.
Journal:	Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):505-21.
Title:	A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer.
Author:	Modjtahedi, Helmout\|Cho, Byoung Chul\|Michel, Martin C\|Solca, Flavio
PMID:	24643470

188.
Journal:	Oncol Rep. 2014 May;31(5):2187-94.
Title:	Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: new insight into the presence of the transcript variant of MUC4.
Author:	Xie, Kunling\|Zhi, Xiaofei\|Tang, Jie\|Zhu, Yi\|Zhang, Jingjing\|Li, Zheng\|Tao, Jinqiu\|Xu, Zekuan
PMID:	24676527

189.
Journal:	Exp Cell Res. 2014 Aug 15;326(2):307-14.
Title:	Induction of pancreatic cancer cell migration by an autocrine epidermal growth factor receptor activation.
Author:	Stock, Anna-Maria\|Hahn, Stephan A\|Troost, Gabriele\|Niggemann, Bernd\|Zanker, Kurt S\|Entschladen, Frank
PMID:	24810090

190.
Journal:	Mol Cancer. 2014 May 29;13:130.
Title:	Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
Author:	Zhang, Jing-Jing\|Zhu, Yi\|Xie, Kun-Ling\|Peng, Yun-Peng\|Tao, Jin-Qiu\|Tang, Jie\|Li, Zheng\|Xu, Ze-Kuan\|Dai, Cun-Cai\|Qian, Zhu-Yin\|Jiang, Kui-Rong\|Wu, Jun-Li\|Gao, Wen-Tao\|Du, Qing\|Miao, Yi
PMID:	24884523

191.
Journal:	Pharmacol Res. 2014 Sep;87:42-59.
Title:	ErbB/HER protein-tyrosine kinases: Structures and small molecule inhibitors.
Author:	Roskoski, Robert Jr
PMID:	24928736

192.
Journal:	PLoS One. 2014 Jun 20;9(6):e97239.
Title:	Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.
Author:	Shan, Tao\|Lu, Hongwei\|Ji, Hong\|Li, Yiming\|Guo, Jian\|Chen, Xi\|Wu, Tao
PMID:	24949874

193.
Journal:	Int J Nanomedicine. 2014 Jun 18;9:2933-42.
Title:	Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy.
Author:	Arora, Sumit\|Swaminathan, Suresh K\|Kirtane, Ameya\|Srivastava, Sanjeev K\|Bhardwaj, Arun\|Singh, Seema\|Panyam, Jayanth\|Singh, Ajay P
PMID:	24971005

194.
Journal:	Neoplasia. 2014 Jul;16(7):562-71.
Title:	Co-treatment with panitumumab and trastuzumab augments response to the MEK inhibitor trametinib in a patient-derived xenograft model of pancreatic cancer.
Author:	Lindberg, James M\|Newhook, Timothy E\|Adair, Sara J\|Walters, Dustin M\|Kim, Alison J\|Stelow, Edward B\|Parsons, J Thomas\|Bauer, Todd W
PMID:	25117978

195.
Journal:	Mol Ther. 2014 Dec;22(12):2056-68.
Title:	Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies.
Author:	Ranzani, Marco\|Annunziato, Stefano\|Calabria, Andrea\|Brasca, Stefano\|Benedicenti, Fabrizio\|Gallina, Pierangela\|Naldini, Luigi\|Montini, Eugenio
PMID:	25195596

196.
Journal:	Oncotarget. 2014 Aug 30;5(16):7138-48.
Title:	HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models.
Author:	Thomas, Gaelle\|Chardes, Thierry\|Gaborit, Nadege\|Mollevi, Caroline\|Leconet, Wilhem\|Robert, Bruno\|Radosevic-Robin, Nina\|Penault-Llorca, Frederique\|Gongora, Celine\|Colombo, Pierre-Emmanuel\|Lazrek, Yassamine\|Bras-Goncalves, Rui\|Savina, Ariel\|Azria, David\|Bazi
PMID:	25216528

197.
Journal:	Oncotarget. 2014 Sep 15;5(17):7599-609.
Title:	MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer.
Author:	Khan, Sheema\|Ebeling, Mara C\|Zaman, Mohd S\|Sikander, Mohammed\|Yallapu, Murali M\|Chauhan, Neeraj\|Yacoubian, Ashley M\|Behrman, Stephen W\|Zafar, Nadeem\|Kumar, Deepak\|Thompson, Paul A\|Jaggi, Meena\|Chauhan, Subhash C
PMID:	25277192

198.
Journal:	Oncoimmunology. 2014 Dec 21;3(11):e956005.
Title:	IGF-1R peptide vaccines/mimics inhibit the growth of BxPC3 and JIMT-1 cancer cells and exhibit synergistic antitumor effects with HER-1 and HER-2 peptides.
Author:	Foy, Kevin Chu\|Miller, Megan J\|Overholser, Jay\|Donnelly, Siobhan M\|Nahta, Rita\|Kaumaya, Pravin Tp
PMID:	25941587

199.
Journal:	Oncoimmunology. 2014 Dec 21;3(11):e956012.
Title:	HER-3 peptide vaccines/mimics: Combined therapy with IGF-1R, HER-2, and HER-1 peptides induces synergistic antitumor effects against breast and pancreatic cancer cells.
Author:	Miller, Megan Jo\|Foy, Kevin C\|Overholser, Jay P\|Nahta, Rita\|Kaumaya, Pravin Tp
PMID:	25941588

200.
Journal:	Histol Histopathol. 2015 Jan;30(1):87-93.
Title:	Overexpression of proCOL11A1 as a stromal marker of breast cancer.
Author:	Fuentes-Martinez, Nelson\|Garcia-Pravia, Carmen\|Garcia-Ocana, Marcos\|Menendez-Rodriguez, Primitiva\|Del Amo, Jokin\|Suarez-Fernandez, Laura\|Galvan, Jose A\|De los Toyos, Juan R\|Barneo, Luis
PMID:	25005174

201.
Journal:	Gut. 2015 Nov;64(11):1790-9.
Title:	SOX9 regulates ERBB signalling in pancreatic cancer development.
Author:	Grimont, Adrien\|Pinho, Andreia V\|Cowley, Mark J\|Augereau, Cecile\|Mawson, Amanda\|Giry-Laterriere, Marc\|Van den Steen, Geraldine\|Waddell, Nicola\|Pajic, Marina\|Sempoux, Christine\|Wu, Jianmin\|Grimmond, Sean M\|Biankin, Andrew V\|Lemaigre, Frederic P\|Rooman, Ils
PMID:	25336113

202.
Journal:	Pathol Oncol Res. 2015 Jul;21(3):831-8.
Title:	Prognostic value of increased HER2 expression in cancers of pancreas and biliary tree.
Author:	Ata, Alper\|Polat, Ayse\|Serinsoz, Ebru\|Sungur, Mehmet Ali\|Arican, Ali
PMID:	25416598

203.
Journal:	Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Jan;119(1):e13-9.
Title:	mTOR inhibitor-associated stomatitis (mIAS) in three patients with cancer treated with everolimus.
Author:	Kalogirou, Eleni-Marina\|Tosios, Konstantinos I\|Piperi, Evangelia P\|Sklavounou, Alexandra
PMID:	25442249

204.
Journal:	Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):839-44.
Title:	Examination of HER3 targeting in cancer using monoclonal antibodies.
Author:	Gaborit, Nadege\|Abdul-Hai, Ali\|Mancini, Maicol\|Lindzen, Moshit\|Lavi, Sara\|Leitner, Orith\|Mounier, Lucile\|Chentouf, Myriam\|Dunoyer, Sai\|Ghosh, Manjusha\|Larbouret, Christel\|Chardes, Thierry\|Bazin, Herve\|Pelegrin, Andre\|Sela, Michael\|Yarden, Yosef
PMID:	25564668

205.
Journal:	Oncotarget. 2015 Mar 10;6(7):5164-81.
Title:	Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer.
Author:	Seshacharyulu, Parthasarathy\|Ponnusamy, Moorthy P\|Rachagani, Satyanarayana\|Lakshmanan, Imayavaramban\|Haridas, Dhanya\|Yan, Ying\|Ganti, Apar K\|Batra, Surinder K
PMID:	25686822

206.
Journal:	Nature. 2015 Feb 26;518(7540):495-501.
Title:	Whole genomes redefine the mutational landscape of pancreatic cancer.
Author:	Waddell, Nicola\|Pajic, Marina\|Patch, Ann-Marie\|Chang, David K\|Kassahn, Karin S\|Bailey, Peter\|Johns, Amber L\|Miller, David\|Nones, Katia\|Quek, Kelly\|Quinn, Michael C J\|Robertson, Alan J\|Fadlullah, Muhammad Z H\|Bruxner, Tim J C\|Christ, Angelika N\|Harliwong,
PMID:	25719666

207.
Journal:	Clin Cancer Res. 2015 Aug 1;21(15):3412-9.
Title:	First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014.
Author:	Basu, Bristi\|Dean, Emma\|Puglisi, Martina\|Greystoke, Alastair\|Ong, Michael\|Burke, Wendy\|Cavallin, Maria\|Bigley, Graham\|Womack, Christopher\|Harrington, Elizabeth A\|Green, Stephen\|Oelmann, Elisabeth\|de Bono, Johann S\|Ranson, Malcolm\|Banerji, Udai
PMID:	25805799

208.
Journal:	Oncotarget. 2015 May 10;6(13):10853-67.
Title:	The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells via hCNT1 transporter and multidrug-resistance associated protein MRP-2.
Author:	Skrypek, Nicolas\|Vasseur, Romain\|Vincent, Audrey\|Duchene, Belinda\|Van Seuningen, Isabelle\|Jonckheere, Nicolas
PMID:	25890497

209.
Journal:	Biomaterials. 2015;53:731-43.
Title:	Nanoparticle formulation of ormeloxifene for pancreatic cancer.
Author:	Khan, Sheema\|Chauhan, Neeraj\|Yallapu, Murali M\|Ebeling, Mara C\|Balakrishna, Swathi\|Ellis, Robert T\|Thompson, Paul A\|Balabathula, Pavan\|Behrman, Stephen W\|Zafar, Nadeem\|Singh, Man M\|Halaweish, Fathi T\|Jaggi, Meena\|Chauhan, Subhash C
PMID:	25890768

210.
Journal:	Clin Cancer Res. 2015 May 1;21(9):2029-37.
Title:	Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial.
Author:	Chantrill, Lorraine A\|Nagrial, Adnan M\|Watson, Clare\|Johns, Amber L\|Martyn-Smith, Mona\|Simpson, Skye\|Mead, Scott\|Jones, Marc D\|Samra, Jaswinder S\|Gill, Anthony J\|Watson, Nicole\|Chin, Venessa T\|Humphris, Jeremy L\|Chou, Angela\|Brown, Belinda\|Morey, Adrienne
PMID:	25896973

211.
Journal:	Oncotarget. 2015 May 20;6(14):12796-808.
Title:	Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the "THERAPY"phase 1-2 trial.
Author:	Assenat, Eric\|Azria, David\|Mollevi, Caroline\|Guimbaud, Rosine\|Tubiana-Mathieu, Nicole\|Smith, Denis\|Delord, Jean-Pierre\|Samalin, Emmanuelle\|Portales, Fabienne\|Larbouret, Christel\|Robert, Bruno\|Bibeau, Frederic\|Bleuse, Jean-Pierre\|Crapez, Evelyne\|Ychou, Mar
PMID:	25918250

212.
Journal:	Oncotarget. 2015 Aug 21;6(24):20132-44.
Title:	Combined targeting of EGFR/HER promotes anti-tumor efficacy in subsets of KRAS mutant lung cancer resistant to single EGFR blockade.
Author:	Umelo, Ijeoma Adaku\|De Wever, Olivier\|Kronenberger, Peter\|Van Deun, Jan\|Noor, Alfiah\|Singh, Kshitiz\|Teugels, Erik\|Chen, Gang\|Bracke, Marc\|De Greve, Jacques
PMID:	25992771

213.
Journal:	Oncotarget. 2015 Aug 28;6(25):21085-99.
Title:	Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells.
Author:	Lakshmanan, Imayavaramban\|Seshacharyulu, Parthasarathy\|Haridas, Dhanya\|Rachagani, Satyanarayana\|Gupta, Suprit\|Joshi, Suhasini\|Guda, Chittibabu\|Yan, Ying\|Jain, Maneesh\|Ganti, Apar K\|Ponnusamy, Moorthy P\|Batra, Surinder K
PMID:	26035354

214.
Journal:	Int J Mol Sci. 2015 Aug 17;16(8):19447-57.
Title:	Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.
Author:	Gonzalez-Alonso, Paula\|Chamizo, Cristina\|Moreno, Victor\|Madoz-Gurpide, Juan\|Carvajal, Nerea\|Daoud, Lina\|Zazo, Sandra\|Martin-Aparicio, Ester\|Cristobal, Ion\|Rincon, Raul\|Garcia-Foncillas, Jesus\|Rojo, Federico
PMID:	26287187

215.
Journal:	J Mol Diagn. 2015 Sep;17(5):487-95.
Title:	Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers.
Author:	Wen, Wenhsiang\|Chen, Wangjuh Sting\|Xiao, Nick\|Bender, Ryan\|Ghazalpour, Anatole\|Tan, Zheng\|Swensen, Jeffrey\|Millis, Sherri Z\|Basu, Gargi\|Gatalica, Zoran\|Press, Michael F
PMID:	26320869

216.
Journal:	Pancreas. 2016 Mar;45(3):425-33.
Title:	Nab-Paclitaxel Plus S-1 Shows Increased Antitumor Activity in Patient-Derived Pancreatic Cancer Xenograft Mouse Models.
Author:	Li, Jian-Ang\|Xu, Xue-Feng\|Han, Xu\|Fang, Yuan\|Shi, Chen-Ye\|Jin, Da-Yong\|Lou, Wen-Hui
PMID:	26495780

217.
Journal:	Expert Opin Biol Ther. 2016;16(2):243-53.
Title:	Pertuzumab in gastrointestinal cancer.
Author:	Oh, Do-Youn\|Bang, Yung-Jue
PMID:	26619359

218.
Journal:	Target Oncol. 2016 Jun;11(3):371-81.
Title:	Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.
Author:	Huguet, Florence\|Fernet, Marie\|Giocanti, Nicole\|Favaudon, Vincent\|Larsen, Annette K
PMID:	26668065

219.
Journal:	PLoS One. 2016 Jan 25;11(1):e0147995.
Title:	A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.
Author:	Shultz, David B\|Pai, Jonathan\|Chiu, Wayland\|Ng, Kendall\|Hellendag, Madeline G\|Heestand, Gregory\|Chang, Daniel T\|Tu, Dongsheng\|Moore, Malcolm J\|Parulekar, Wendy R\|Koong, Albert C
PMID:	26808546

220.
Journal:	Anticancer Res. 2016 Feb;36(2):517-21.
Title:	Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Author:	Jun, Eunsung\|Jung, Jaeyoon\|Jeong, Seong-Yun\|Choi, Eun Kyung\|Kim, Moon Bo\|Lee, Ji Sun\|Hong, Seung-Mo\|Seol, Hyang Sook\|Hwang, Changmo\|Hoffman, Robert M\|Shim, In Kyong\|Chang, Suhwan\|Kim, Song Cheol
PMID:	26851005

221.
Journal:	World J Surg Oncol. 2016 Feb 20;14(1):38.
Title:	Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis.
Author:	Li, Xiaoping\|Zhao, Hua\|Gu, Jianchun\|Zheng, Leizhen
PMID:	26897036

222.
Journal:	Oncol Lett. 2016 Mar;11(3):1645-1650.
Title:	Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.
Author:	Tian, Xuefei\|Shivapurkar, Narayan\|Wu, Zheng\|Hwang, Jimmy J\|Pishvaian, Michael J\|Weiner, Louis M\|Ley, Lisa\|Zhou, Dan\|Zhi, Xiuling\|Wellstein, Anton\|Marshall, John L\|He, Aiwu Ruth
PMID:	26998056

223.
Journal:	PLoS One. 2016 Apr 12;11(4):e0153533.
Title:	Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.
Author:	Elebro, Jacob\|Heby, Margareta\|Warfvinge, Carl Fredrik\|Nodin, Bjorn\|Eberhard, Jakob\|Jirstrom, Karin
PMID:	27070783

224.
Journal:	Br J Cancer. 2016 Jun 14;114(12):1376-86.
Title:	Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Author:	Chugh, Seema\|Meza, Jane\|Sheinin, Yuri M\|Ponnusamy, Moorthy P\|Batra, Surinder K
PMID:	27187683

225.
Journal:	Cancer Lett. 2016 Aug 28;379(1):143-53.
Title:	Combined targeting of TGF-beta, EGFR and HER2 suppresses lymphangiogenesis and metastasis in a pancreatic cancer model.
Author:	Gore, Jesse\|Imasuen-Williams, Imade E\|Conteh, Abass M\|Craven, Kelly E\|Cheng, Monica\|Korc, Murray
PMID:	27267807

226.
Journal:	Cancer Genet. 2016 Dec;209(12):567-581.
Title:	Molecular targeted therapy for pancreatic adenocarcinoma: A review of completed and ongoing late phase clinical trials.
Author:	Mosquera, Catalina\|Maglic, Dino\|Zervos, Emmanuel E
PMID:	27613577

227.
Journal:	Expert Opin Biol Ther. 2016 Dec;16(12):1549-1555.
Title:	The prospect of patritumab for treating non-small cell lung cancer.
Author:	Horinouchi, Hidehito
PMID:	27744717

228.
Journal:	BMC Cancer. 2016 Nov 21;16(1):910.
Title:	The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer.
Author:	Li, Qin\|Zhang, Lei\|Li, XiuHong\|Yan, Han\|Yang, Liuting\|Li, Yingying\|Li, Teng\|Wang, Jing\|Cao, Bangwei
PMID:	27871278

229.
Journal:	Nature. 2016 Dec 14. pii: nature20609.
Title:	Mechanism of early dissemination and metastasis in Her2(+) mammary cancer.
Author:	Harper, Kathryn L\|Sosa, Maria Soledad\|Entenberg, David\|Hosseini, Hedayatollah\|Cheung, Julie F\|Nobre, Rita\|Avivar-Valderas, Alvaro\|Nagi, Chandandaneep\|Girnius, Nomeda\|Davis, Roger J\|Farias, Eduardo F\|Condeelis, John\|Klein, Christoph A\|Aguirre-Ghiso, Julio
PMID:	27974798

230.
Journal:	Oncotarget. 2017 Feb 14;8(7):10785-10808.
Title:	Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens.
Author:	Pathangey, Latha B\|McCurry, Dustin B\|Gendler, Sandra J\|Dominguez, Ana L\|Gorman, Jessica E\|Pathangey, Girish\|Mihalik, Laurie A\|Dang, Yushe\|Disis, Mary L\|Cohen, Peter A
PMID:	27974697

231.
Journal:	Sci Rep. 2017 Jul 3;7(1):4537.
Title:	Citrate Suppresses Tumor Growth in Multiple Models through Inhibition of Glycolysis, the Tricarboxylic Acid Cycle and the IGF-1R Pathway.
Author:	Ren, Jian-Guo\|Seth, Pankaj\|Ye, Huihui\|Guo, Kun\|Hanai, Jun-Ichi\|Husain, Zaheed\|Sukhatme, Vikas P
PMID:	28674429

232.
Journal:	J Gastrointest Oncol. 2017 Jun;8(3):405-417.
Title:	Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment.
Author:	Verdaguer, Helena\|Sauri, Tamara\|Macarulla, Teresa
PMID:	28736628

233.
Journal:	Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):394-403.
Title:	Clinical value of ctDNA in upper-GI cancers: A systematic review and meta-analysis.
Author:	Creemers, A\|Krausz, S\|Strijker, M\|van der Wel, M J\|Soer, E C\|Reinten, R J\|Besselink, M G\|Wilmink, J W\|van de Vijver, M J\|van Noesel, C J M\|Verheij, J\|Meijer, S L\|Dijk, F\|Bijlsma, M F\|van Oijen, M G H\|van Laarhoven, H W M
PMID:	28801248

234.
Journal:	Oncotarget. 2017 Apr 29;8(33):54592-54603.
Title:	Exploratory investigation of PSCA-protein expression in primary breast cancer patients reveals a link to HER2/neu overexpression.
Author:	Link, Theresa\|Kuithan, Friederike\|Ehninger, Armin\|Kuhlmann, Jan Dominik\|Kramer, Michael\|Werner, Andreas\|Gatzweiler, Axel\|Richter, Barbara\|Ehninger, Gerhard\|Baretton, Gustavo\|Bachmann, Michael\|Wimberger, Pauline\|Friedrich, Katrin
PMID:	28903367

235.
Journal:	Monoclon Antib Immunodiagn Immunother. 2017 Dec;36(6):287-290.
Title:	Establishment of H2Mab-119, an Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody, Against Pancreatic Cancer.
Author:	Yamada, Shinji\|Itai, Shunsuke\|Nakamura, Takuro\|Chang, Yao-Wen\|Harada, Hiroyuki\|Suzuki, Hiroyoshi\|Kaneko, Mika K\|Kato, Yukinari
PMID:	29172998

236.
Journal:	Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):486-489.
Title:	Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Author:	Rao, Avani D\|Liu, Yufei\|von Eyben, Rie\|Hsu, Charles C\|Hu, Chen\|Rosati, Lauren M\|Parekh, Arti\|Ng, Kendall\|Hacker-Prietz, Amy\|Zheng, Lei\|Pawlik, Timothy M\|Laheru, Daniel A\|Jaffee, Elizabeth M\|Weiss, Matthew J\|Le, Dung T\|Hruban, Ralph H\|De Jesus-Acosta, Ana\|
PMID:	29157747

237.
Journal:	Cancer Sci. 2018 Feb;109(2):373-383.
Title:	PRDM14 directly interacts with heat shock proteins HSP90alpha and glucose-regulated protein 78.
Author:	Moriya, Chiharu\|Taniguchi, Hiroaki\|Nagatoishi, Satoru\|Igarashi, Hisayoshi\|Tsumoto, Kouhei\|Imai, Kohzoh
PMID:	29178343

238.
Journal:	J Oncol Pharm Pract. 2018 Apr;24(3):209-217.
Title:	Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimens.
Author:	Yan, Lily Z\|Dressler, Emily V\|Adams, Val R
PMID:	29284349

239.
Journal:	Oncogenesis. 2018 Feb 22;7(2):19.
Title:	MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer.
Author:	Kumari, Sonam\|Khan, Sheema\|Gupta, Subash C\|Kashyap, Vivek K\|Yallapu, Murali M\|Chauhan, Subhash C\|Jaggi, Meena
PMID:	29467405

240.
Journal:	Sci Rep. 2018 Mar 15;8(1):4595.
Title:	Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots.
Author:	Ramos-Gomes, Fernanda\|Bode, Julia\|Sukhanova, Alyona\|Bozrova, Svetlana V\|Saccomano, Mara\|Mitkovski, Miso\|Krueger, Julia Eva\|Wege, Anja K\|Stuehmer, Walter\|Samokhvalov, Pavel S\|Baty, Daniel\|Chames, Patrick\|Nabiev, Igor\|Alves, Frauke
PMID:	29545609

241.
Journal:	Sci Rep. 2018 Apr 18;8(1):6150.
Title:	Overexpression of HER2 in the pancreas promotes development of intraductal papillary mucinous neoplasms in mice.
Author:	Shibata, Wataru\|Kinoshita, Hiroto\|Hikiba, Yohko\|Sato, Takeshi\|Ishii, Yasuaki\|Sue, Soichiro\|Sugimori, Makoto\|Suzuki, Nobumi\|Sakitani, Kosuke\|Ijichi, Hideaki\|Mori, Ryutaro\|Endo, Itaru\|Maeda, Shin
PMID:	29670173

242.
Journal:	Cancers (Basel). 2018 May 14;10(5). pii: cancers10050142.
Title:	A New Strategy to Control and Eradicate "Undruggable" Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology.
Author:	Van Sciver, Robert E\|Lee, Michael P\|Lee, Caroline Dasom\|Lafever, Alex C\|Svyatova, Elizaveta\|Kanda, Kevin\|Colliver, Amber L\|Siewertsz van Reesema, Lauren L\|Tang-Tan, Angela M\|Zheleva, Vasilena\|Bwayi, Monicah N\|Bian, Minglei\|Schmidt, Rebecca L\|Matrisian, Ly
PMID:	29757973

243.
Journal:	Gut. 2018 Aug 18. pii: gutjnl-2018-316595.
Title:	Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma.
Author:	Raj, Deepak\|Yang, Ming-Hsin\|Rodgers, David\|Hampton, Eric N\|Begum, Julfa\|Mustafa, Arif\|Lorizio, Daniela\|Garces, Irene\|Propper, David\|Kench, James G\|Young, Travis S\|Aicher, Alexandra\|Heeschen, Christopher
PMID:	30121627

244.
Journal:	Curr Treat Options Oncol. 2018 Aug 20;19(10):48.
Title:	Harnessing the Immune System in Pancreatic Cancer.
Author:	Das, Satya\|Berlin, Jordan\|Cardin, Dana
PMID:	30128712

245.
Journal:	Medicine (Baltimore). 2018 Sep;97(36):e11878.
Title:	Incidental finding of a breast carcinoma on Ga-68-DOTA-1-Nal3-octreotide positron emission tomography/computed tomography performed for the evaluation of a pancreatic neuroendocrine tumor: A case report.
Author:	Sampaio Vieira, Tiago\|Borges Faria, Diogo\|Souto Moura, Conceicao\|Francisco, Elsa\|Barroso, Sergio\|Pereira de Oliveira, Jose
PMID:	30200073

246.
Journal:	Gene. 2018 Sep 15;679:328-334.
Title:	Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis.
Author:	Chen, Linyan\|Zhang, Yi\|Cheng, Yuan\|Zhang, Dan\|Zhu, Sha\|Ma, Xuelei
PMID:	30227250

247.
Journal:	Cancer Immunol Res. 2018 Oct 19. pii: 2326-6066.CIR-18-0070.
Title:	Entinostat converts immune-resistant breast and pancreatic cancers into checkpoint-responsive tumors by reprogramming tumor-infiltrating MDSCs.
Author:	Christmas, Brian J\|Rafie, Christine I\|Hopkins, Alexander C\|Scott, Blake A\|Ma, Hayley S\|Cruz, Kayla A\|Woolman, Skylar\|Armstrong, Todd D\|Connolly, Roisin M\|Azad, Nilofer A\|Jaffee, Elizabeth M\|Roussos Torres, Evanthia T
PMID:	30341213

248.
Journal:	Oncologist. 2018 Oct 29. pii: theoncologist.2018-0152.
Title:	Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal Malignancies.
Author:	Mitra, Devarati\|Clark, Jeffrey W\|Shih, Helen A\|Oh, Kevin S\|Brastianos, Priscilla K\|Wo, Jennifer Y\|Strickland, Matthew R\|Curry, William T\|Parikh, Aparna R\|Corcoran, Ryan B\|Ryan, David P\|Iafrate, A John\|Borger, Darrell R\|Lennerz, Jochen K\|Hong, Theodore S
PMID:	30373904

249.
Journal:	Toxins (Basel). 2018 Oct 31;10(11). pii: toxins10110447.
Title:	Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors.
Author:	El-Behaedi, Salma\|Landsman, Rebekah\|Rudloff, Michael\|Kolyvas, Emily\|Albalawy, Rakan\|Zhang, Xianyu\|Bera, Tapan\|Collins, Keith\|Kozlov, Serguei\|Alewine, Christine
PMID:	30384408